Candel Therapeutics, Inc.
← Back to CADL Overview

Candel Therapeutics, Inc. (CADL)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-8.75

Financial Fundamentals

CADLQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-18.48
2020-06-30-11.67
2020-09-30-12.50
2020-12-31-3.12
2021-03-31-7.29
2021-06-30-2.54
2021-09-30-3.93
2021-12-3128.79
2022-03-315.09
2022-06-3051.27
2022-09-30-2.71
2022-12-311.21
2023-03-31-1.13
2023-06-30-0.95
2023-09-30-0.79
2023-12-31-0.97
2024-03-31-1.56
2024-06-30-2.13
2024-09-30-5.25
2024-12-31-5.42
2025-03-316.14
2025-06-30-13.59
2025-09-30-6.07
2025-12-31-2.62
2026-03-31-8.75

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Candel Therapeutics, Inc. (CADL) P/E Ratio History & Valuation Cycles